Company intelligence / Profile preview

OOFOS

Braintree, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

OOFOS’s OOfoam™ technology is clinically validated to absorb 37% more impact than traditional foam materials, resulting in reduced joint and muscle stress and improved recovery. Products have earned the APMA Seal of Acceptance for therapeutic benefit and are favored by athletes and medical professionals

Therapeutic areas: OtherRheumatology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Dana-Farber Cancer Institute & Jimmy Fund (Project Pink for breast cancer research)Pan-Mass Challenge (official recovery footwear)U.S. Ski & SnowboardUSA GymnasticsNWHLRE–INC (collab with USWNT players)APMA (Seal of Acceptance)

Beyond the preview

Go deeper on OOFOS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OOFOS.

Explore the full profile